Clinical trial
Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder
NCT00149799 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- March 31, 2013
- Enrollment
- 100 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.